Code of Maryland Regulations
Title 10 - MARYLAND DEPARTMENT OF HEALTH
Part 4
Subtitle 34 - BOARD OF PHARMACY
Chapter 10.34.35 - Infusion Pharmacy Services in an Alternate Site Care Environment
Section 10.34.35.04 - Pharmacist Responsibilities

Universal Citation: MD Code Reg 10.34.35.04

Current through Register Vol. 51, No. 19, September 20, 2024

A. A pharmacist in an infusion pharmacy shall adhere to the policies and procedures set forth in Regulation .06 of this chapter.

B. A pharmacist shall:

(1) Provide infusion therapy services in accordance with:
(a) Orders issued by a licensed authorized prescriber of record; and

(b) Where applicable, protocols issued by a licensed authorized prescriber of record.

(2) Perform and document initial and ongoing assessments of the appropriateness of infusion therapy using the following information:
(a) Patient demographics including:
(i) Name;

(ii) Address;

(iii) Telephone number;

(iv) Gender; and

(v) Date of birth;

(b) Emergency contact information;

(c) Diagnoses, including:
(i) Diagnosis being treated; and

(ii) Concurrent conditions, including pregnancy and lactation status if applicable;

(d) Medical history;

(e) Allergies;

(f) If applicable, height;

(g) Weight;

(h) Parenteral medication orders, including length of therapy;

(i) Parenteral infusion access device:
(i) Location;

(ii) Type; and

(iii) If available, date of placement;

(j) Ongoing medication profile review and reconciliation at end of therapy;

(k) First dose status;

(l) Caregiver information including, but not limited to:
(i) Name;

(ii) Address;

(iii) Phone number; and

(iv) Relationship to patient;

(m) If applicable, contact information for other agencies or individuals involved in the patient's home care;

(n) Documented applicable medical and social factors and functional limitations which may affect infusion therapy including but not limited to:
(i) Language;

(ii) Sight;

(iii) Hearing;

(iv) History of IV drug abuse;

(v) History of drug or alcohol abuse; or

(vi) Other physical or mental limitations; and

(o) If applicable to therapy, baseline labs;

(3) Create a patient care plan specific to the patient's:
(a) Diagnosis;

(b) Prescribed therapy; and

(c) Concurrent conditions;

(4) When compounding sterile preparations, comply with COMAR 10.34.19;

(5) If sterile compounding is outsourced, comply with COMAR 10.34.04;

(6) As applicable, retrieve and assess lab values and other monitoring parameters;

(7) Document in the patient chart:
(a) New prescription orders;

(b) Changes in prescription orders;

(c) Information obtained from the patient or caregiver; and

(d) Other necessary information obtained from the:
(i) Patient;

(ii) Caregiver;

(iii) Infusion nurse;

(iv) Licensed authorized prescriber of record; or

(v) Other sources relevant to patient care;

(8) Verify prescription label accuracy;

(9) Communicate as appropriate, throughout the patient's therapy with the:
(a) Licensed authorized prescriber of record or agent of the licensed authorized prescriber of record;

(b) Patient's infusion nurse;

(c) Patient; and

(d) Caregiver; and

(10) Review therapy-specific considerations such as pain and nutrition status.

Disclaimer: These regulations may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.